Since its foundation, 57 years ago, Uni-Pharma has grown from a small privately held company into a large and dynamic company, which currently holds the first position in unit sales among companies in the Greek pharmaceutical market. Uni-Pharma researches, develops, manufactures, markets and distributes pharmaceuticals, nutritional products and medical devices. Uni-Pharma's dynamic growth is based on investments in research and development, as well as on a working style, designed to develop sta skills and to encourage individual contribution and creativity. The production capacity exceeds 21 million pieces annually, making the UNI-PHARMA the first Greek company in unit sales in the Greek market.

Related Categories

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)